C17H15IN 2 O, monoclinic, C2 (no. 5), a = 23.6958(12) Å, b = 5.5334(2) Å, c = 15.9712(9) Å, β = 132.329(3)°, V = 1548.16(13) Å 3 , Z = 4, Rgt(F) = 0.046, wR ref (F 2 ) = 0.093, T = 296(2) K.
Experimental details
The structure was solved by direct methods. All non-H atoms were refined with anisotropic displacement parameters. H-atoms were refined using the SHELXL [1] riding model using the appropriate AFIX commands. The Flack parameter was refined to −0.03 (3) .
Comment
Epilepsy is one of the most common neurological problems in the world upsetting 1% of the population [3] . Methaqualone is one of the most important anticonvulsant drugs containing the quinazoline pharmacophore [4] . New derivative of methaqualone was prepared and evaluated for their anticonvulsant activity in mice. The results of this study demonstrated that 3-substituted-4(3H)quinazolinone derivatives control a good anticonvulsant activity [4, [6] [7] [8] [9] .
In our laboratory, research efforts have concentrated on synthesizing quinazoline derivatives with substituted moieties having high lipophilic properties in the hope of developing effective and safe compounds [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Herein, we report the crystal structure of 6-iodo-3-phenyl-2-propylquinazolin-4(3H)-one as a methaqualone analogue.
The asymmetric unit of the title compound contains one independent molecule. Geometric parameters are in the expected range [19] . The quinazolin-4(3H)-one ring (N1/C1-C7/N2/C8) makes a nearly perpendicular dihedral angle of 88.81°with the phenyl ring (C12-C17). The molecules pack via non-classical intermolecular hydrogen bonds C13-H13A· · · O1 i and C15-H15A· · · O1 ii . Symmetry codes: (i) x, y − 1, z, (ii) 1.5 − x, −1/2 + y, 2 − z [D· · · A distances of 3.370(6) and 3.453(6) Å, respectively; D-H· · · A angle of 144.1 and 137.0°, respectively].
